Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0001193805-23-001075

Chief Scientific Officer & COO sold 5,000 shares at $34.91 ($174,550)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chivukula Pad Chief Scientific Officer & COO 2023-08-01 Sale 10b5-1 −5,000 $34.91 $174,550 514,448 D
Open-market sales · 5,000 sh · avg $34.91 · $174,550
Loading xslF345X05/e618822_4-chivukula.xml…